Jornal de Imunologia Clínica e Celular
Acesso livre

Abstrato

Relationship of Gender, Use of Disease-Modifying Therapies, and Health Insurance in Multiple Sclerosis

Guoqiao Wang and Amber R Salter

Recent findings have demonstrated that use of disease-modifying therapies (DMTs) in persons with multiple sclerosis was affected by health insurance. Many patients relied on free or discounted drug programs for DMT use and when they obtained DMTs through their health insurance, it was not uncommon for them to experience insurance challenges for DMT use. However, it is not known how these findings were associated with gender. Here we investigate the association between gender and (1) DMT use, (2) use of free or discounted drug programs, and (3) insurance challenges for DMT use using participants from North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.